The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Research & Development Programmes

19 Nov 2015 07:00

RNS Number : 2163G
Quadrise Fuels International PLC
19 November 2015
 

19 November 2015

 

Quadrise Fuels International plc

("QFI", "Quadrise" or the "Company")

 

Research & Development Programmes

 

 

Quadrise, the emerging supplier of MSAR, a low cost alternative to heavy fuel oil in the shipping, oil refining and power generation markets, is pleased to provide the following update on its Research & Development programmes.

 

A Collaboration Agreement was executed with the University of Surrey in Guildford (the "University") on 18 November 2015 (the "Agreement") which provides for the shared use of the University's Centre for Petroleum and Surface Chemistry ("CPSC"), an advanced research facility under the supervision of Professor Spencer Taylor within the Department of Chemistry. The consideration payable by Quadrise to the University for the first twelve months under the Agreement, which is renewable annually, is £78,000. As a result, the Company is relocating its primary emulsion fuels research base from Sweden to the UK.

 

In a related development, the existing Quadrise Research Facility ("QRF") in Essex is being expanded to meet anticipated business support requirements and to develop new MSAR formulations in collaboration with the University.

 

The programme at the University will be directed by Professor Taylor, a world class expert on surfactant and emulsion technology with over 20 years' experience in the petroleum industry with BP, undertaking applied research to underpin intellectual property, as well as upstream and downstream businesses. The CPSC has first class facilities and is ideally equipped with additional hardware and expertise to meet QFI's primary and applied research needs.

 

The intellectual property developed from applied research projects under the Agreement will be exclusively owned by Quadrise, whilst any fundamental research/intellectual property developed under the Agreement will be the property of the University, with Quadrise granted a non-exclusive, royalty free licence - with the option of exclusive rights based on a negotiated settlement. Quadrise will have exclusive rights on intellectual property created from jointly conducted research.

 

The overall research programme will be coordinated with the QRF and tightly aligned with future business needs and imperatives to extend and strengthen the Company's existing competitive advantage.

 

In view of these developments, the primary research programme previously coordinated by Dr Simon Craige in Sweden has been transferred to the UK to facilitate cost effective control and coordination. Dr Craige wished to remain domiciled in Scandinavia for personal reasons and left the Company's employment on 31 October 2015, following an amicable contractual separation.

 

Commenting on these developments, Ian Williams, Executive Chairman of QFI, said:

 

"The agreement with the University of Surrey, together with the relocation of primary research and the extension of QRF, results in the consolidation, expansion and strengthening of all our R&D activities to better serve the anticipated future needs of the Company. We are delighted to be working with Professor Taylor and his team, and to have established the framework for a long term relationship with the University."

 

Professor Dulcie Mulholland, Head of the Department of Chemistry, said:

 

"The University of Surrey and the Department of Chemistry are delighted to establish a relationship with Quadrise. Professor Taylor of our Centre for Petroleum and Surface Chemistry is a leading researcher in this field. We look forward to a long, productive relationship with the company"

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Ian Williams, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

Jason Miles, Chief Operating Officer

 

Nominated Adviser

Smith & Williamson Corporate Finance Limited

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

Broker

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

Alastair Rae

 

Public & Investor Relations

Bell Pottinger

Rollo Crichton-Stuart

+44 (0)20 7861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFLFWAFISEEF
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.